查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1233126

2023-2030 年按類型、配方、分銷渠道、產品類型、細分趨勢分列的視網膜疾病治療市場規模、份額和趨勢分析報告

Retinal Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Macular Degeneration, Diabetic Retinopathy), By Dosage Form, By Distribution Channel, By Product Type, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

視網膜疾病治療市場的增長和趨勢

根據 Grand View Research, Inc. 的最新報告，2023 年至 2030 年全球視網膜疾病治療市場規模預計將達到 256.9 億美元，複合年增長率為 9.3%。

市場增長的驅動力是全球視網膜病變的日益流行以及對負擔得起的有效治療的需求未得到滿足。此外，增加與眼病相關研發的監管資金預計將進一步推動市場增長。

視網膜疾病是世界人口視力受損的主要原因之一。據世界衛生組織稱，到 2022 年，全球將至少有 22 億人患有近視或遠視。其中將近一半（約 10 億人）的視力問題本可以避免或尚未得到解決。生活方式的改變、預期壽命的延長以及高血壓和糖尿病等全身性疾病的流行等因素是視網膜損傷的最常見原因。這表明視網膜疾病患者的治療需求未得到滿足。

年齡相關性黃斑變性 (AMD) 是 65 歲以上人群視力喪失的主要原因之一。AMD 的特徵是稱為黃斑的視網膜區域退化，該區域負責中央視力。預計不斷增長的老年人口將為 AMD 治療創造更廣泛的患者基礎。例如，根據 2021 年世界衛生組織的一份報告，到 2030 年，世界上六分之一的人將年滿 60 歲。此外，60 歲及以上的人口預計將從 2020 年的 10 億增長到 14 億。

與視網膜疾病治療相關的高成本對市場增長構成威脅。然而，市場上的主要參與者越來越努力開發新產品以加強其產品線，預計將推動市場。例如，2022 年 1 月，Genentech 的 Vabysmo 獲得 FDA 批准，成為治療濕性年齡相關性黃斑變性和糖尿病性黃斑水腫的一流雙特異性抗體。新產品的推出預計將推動市場增長。

視網膜疾病治療市場報告重點

  • 按產品類型劃分，黃斑變性部分由於其高患病率、對該病的認識提高以及有前途的管道產品，將在 2022 年佔據最大的市場份額。
  • 由於其高滲透率和易用性，預計眼用劑型部分在預測期內將以最快的速度增長。
  • 醫院藥房在 2022 年將主導分銷渠道部分，因為它們易於訪問和提供患者記錄。
  • 北美將在 2022 年主導全球市場，並且由於視網膜疾病患病率上升和消費者對視網膜疾病的認識不斷提高，預計未來將顯著增長。
  • 主要參與者包括 Regeneron Pharmaceuticals Inc.、Shire（Takeda Pharmaceutical Company Limited）、Graybug Vision, Inc.、Bayer AG、Santen Pharmaceutical Co., Ltd. 和 Genentech, Inc.。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 段範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查詳情
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法：產品流方法
  • 二級信息列表
  • 縮略語表
  • 目的

2 視網膜疾病治療市場：執行摘要

  • 市場展望
  • 段快照
  • 競爭格局的快照

3. 視網膜疾病治療市場變量、趨勢和範圍

  • 市場系列展望
    • 母市場
  • 流行病學
    • 視網膜疾病
  • 市場動態
    • 市場驅動力分析
      • 目標疾病的患病率增加
      • 強大的管道
      • 老年人口不斷增長
      • 提高對視網膜疾病的認識
    • 市場約束因素分析
      • 治療藥物成本高
  • 繪製滲透率和增長前景
  • 視網膜疾病治療：市場分析工具
    • 行業分析 - 搬運工
    • PESTLE分析
    • 管道分析
    • 重大交易和戰略聯盟
      • 新產品發佈
      • 獲得
      • 擴張
      • 合夥
      • 營銷和推廣

4 視網膜疾病治療市場：細分分析，按類型，2018-2030 年（百萬美元）

  • 定義和範圍
  • 類型市場份額分析，2022 年和 2030 年
  • 細分儀表板
  • 全球視網膜疾病治療市場，按類型，2018-2030
  • 2018-2030年市場規模及預測，趨勢分析
    • 黃斑變性
      • 乾性黃斑變性
      • 濕性黃斑變性
    • 糖尿病性視網膜病變
    • 其他

5 視網膜疾病治療市場：細分分析，按配方，2018-2030 年（百萬美元）

  • 定義和範圍
  • 劑型市場份額分析，2022 年和 2030 年
  • 細分儀表板
  • 全球視網膜疾病治療市場，按配方，2018-2030
  • 2018-2030年市場規模及預測，趨勢分析
    • 凝膠
    • 眼藥水和懸液
    • 膠囊/片劑
    • 眼藥水
    • 軟膏

6 視網膜疾病治療市場：細分分析，按分銷渠道，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年分銷渠道市場份額分析
  • 細分儀表板
  • 全球視網膜疾病治療市場，按分銷渠道，2018-2030 年
  • 2018-2030年市場規模及預測，趨勢分析
    • 醫院藥房
    • 網上藥店
    • 零售藥店

7 視網膜疾病治療市場：細分分析，按地區，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 區域市場快照
  • SWOT 分析，按因素（政治和法律、經濟和技術）
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 多邊環境協定
  • 2018-2030 年市場規模、預測和趨勢分析
  • 北美
    • 美國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 加拿大
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
  • 歐洲
    • 英國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 德國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 西班牙
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 法國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 意大利
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 挪威
      • 監管框架
      • 競爭情景
      • 投資場景
    • 丹麥
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 瑞典
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
  • 亞太地區
    • 日本
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 中國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 印度
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 韓國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 泰國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 澳大利亞
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
  • 拉丁美洲
    • 巴西
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 墨西哥
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 阿根廷
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
  • 多邊環境協定
    • 南非
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 沙特阿拉伯
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景
    • 科威特
      • 主要國家動態
      • 監管框架
      • 競爭情景
      • 投資場景

8 視網膜疾病治療市場——競爭分析

  • 主要市場進入者的最新發展和影響分析
    • 安索夫矩陣
    • 熱圖分析
  • 公司分類
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要經銷商及渠道合作夥伴名單
    • 主要客戶
    • 2022 年主要參與者的市場份額分析
  • 上市公司
    • 公司市場分析
    • 公司各地區市場份額
    • 競爭儀錶盤分析
      • 市場差異化因素
  • 民營企業
    • 主要初創企業名單
  • 公司簡介
    • Graybug Vision, Inc.
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • Shire（Takeda Pharmaceutical Company Limited）
      • 公司簡介
      • 財務績效
      • 產品基準
    • Regeneron Pharmaceuticals Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Acucela Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
    • Allergan Plc.（Abbvie Inc.）
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Pfizer, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
    • Bayer Ag
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Santen Pharmaceuticals Co. Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Genentech, Inc.（F. Hoffmann-La Roche Ltd.）
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Kubota Pharmaceutical Holdings Co., Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-3-68038-766-7

Retinal Disorder Treatment Market Growth & Trends:

The global retinal disorder treatment market size is expected to reach USD 25.69 billion, expanding at a CAGR of 9.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growth in the market is fueled by the increasing prevalence of retinal disorders around the world and the unmet need for affordable and efficient treatments. Furthermore, improved funding by regulatory bodies for R&D associated with ocular disorders is expected to further drive market growth.

Retinal diseases are one of the leading causes of visual impairment among the global population. According to WHO, in 2022, a near or distant vision impairment affects at least 2.2 billion people worldwide. Nearly half of these cases, or around 1 billion, involved vision impairments that either could have been avoided or are still unaddressed. Factors such as changing lifestyles, increased life expectancy, and escalating prevalence of systemic diseases like hypertension and diabetes mellitus are the most common causes of retinal disorders. This demonstrates an unmet need among retinal disorder patients for treatment of the condition.

The rising geriatric population is acting as a driver for the market; age-related macular degeneration (AMD) is one of the leading causes of vision loss in people aged over 65 years. AMD is characterized by the degeneration of an area of the retina known as the macula, which is responsible for central vision. The growing elderly population is expected to create a wider patient pool for the treatment of AMD. For instance, according to a WHO report in 2021, by 2030, 1 in every 6 people in the world will be aged 60 years or over. Furthermore, over this period of time, the population aged over 60 years is expected to increase from 1 billion in 2020 to 1.4 billion.

The high cost associated with retinal disorder treatment poses a threat to the growth of the market. However, increasing efforts from key players operating in the market for developing new products for the enhancement of their product pipeline is expected to drive the market. For instance, in January 2022, Genentech's Vabysmo was approved by the FDA, the first-in-class bispecific antibody for the treatment of wet age-related macular degeneration and diabetic macular edema. The launch of novel products is expected to propel market growth.

Retinal Disorder Treatment Market Report Highlights:

  • By type, the macular degeneration segment held the largest market share in 2022, which is attributable to its high prevalence, rising awareness about the disease, and promising pipeline products
  • Eye drops dosage form segment is projected to grow at the fastest rate over the forecast period due to its high adoption and ease of use
  • Hospital pharmacies held a dominant share of the distribution channel segment in 2022 due to the ease of access and availability of patient records
  • North America dominated the global market in 2022 and is expected to grow considerably in the future, owing to the rising prevalence of retinal disorders and the increasing consumer awareness about retinal disorders
  • A few of the key players include Regeneron Pharmaceuticals Inc., Shire (Takeda Pharmaceutical Company Limited), Graybug Vision, Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., and Genentech, Inc.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Retinal Disorder Treatment Market: Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Retinal Disorder Treatment Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market
  • 3.2 Epidemiology
    • 3.2.1 Retinal Disorders
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers Analysis
      • 3.3.1.1 Increasing Prevalence Of Target Diseases
      • 3.3.1.2 Strong Pipeline
      • 3.3.1.3 Increasing Geriatric Population
      • 3.3.1.4 Rising Awareness Of Retinal Disorders
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High Cost Of Treatment Drugs
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 Retinal Disorder Treatment: Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's
    • 3.5.2 Pestle Analysis
    • 3.5.3 Pipeline Analysis
    • 3.5.4 Major Deals And Strategic Alliances
      • 3.5.4.1 New Product Launch
      • 3.5.4.2 Acquisition
      • 3.5.4.3 Expansion
      • 3.5.4.4 Partnerships
      • 3.5.4.5 Marketing & Promotions

Chapter 4 Retinal Disorder Treatment Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 Definition And Scope
  • 4.2 Type Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Retinal Disorder Treatment Market, By Type, 2018 To 2030
  • 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 4.5.1 Macular Degeneration
      • 4.5.1.1 Macular Degeneration Market, 2018 - 2030 (USD Million)
      • 4.5.1.2 Dry Macular Degeneration
      • 4.5.1.2.1 Dry Macular Degeneration Market, 2018 - 2030 (USD Million)
      • 4.5.1.3 Wet Macular Degeneration
      • 4.5.1.3.1 Wet Macular Degeneration Market, 2018 - 2030 (USD Million)
    • 4.5.2 Diabetic Retinopathy
      • 4.5.2.1 Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
    • 4.5.3 Others
      • 4.5.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Retinal Disorder Treatment Market: Segment Analysis, By Dosage Form, 2018 - 2030 (USD Million)

  • 5.1 Definition And Scope
  • 5.2 Dosage Form Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Retinal Disorder Treatment Market, By Dosage Form, 2018 To 2030
  • 5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 5.5.1 Gels
      • 5.5.1.1 Gels Market, 2018 - 2030 (USD Million)
    • 5.5.2 Eye Solutions & Suspensions
      • 5.5.2.1 Eye Solutions Market, 2018 - 2030 (USD Million)
    • 5.5.3 Capsules & Tablets
      • 5.5.3.1 Capsules & Tablets Market, 2018 - 2030 (USD Million)
    • 5.5.4 Eye Drops
      • 5.5.4.1 Eye Drops Market, 2018 - 2030 (USD Million)
    • 5.5.5 Ointments
      • 5.5.5.1 Ointments Market, 2018 - 2030 (USD Million)

Chapter 6 Retinal Disorder Treatment Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Definition And Scope
  • 6.2 Distribution Channel Market Share Analysis, 2022 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Retinal Disorder Treatment Market, By Distribution Channel, 2018 To 2030
  • 6.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 6.5.1 Hospital Pharmacy
      • 6.5.1.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
    • 6.5.2 Online Pharmacy
      • 6.5.2.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
    • 6.5.3 Retail Pharmacy
      • 6.5.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7 Retinal Disorder Treatment Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Regional Market Dashboard
  • 7.4 Regional Market Snapshot
  • 7.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia Pacific
    • 7.5.4 Latin America
    • 7.5.5 MEA
  • 7.6 Market Size, & Forecasts, Trend Analysis, 2018 To 2030
  • 7.7 North America
    • 7.7.1 North America Retinal Disorder Treatment Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.7.2 U.S.
      • 7.7.2.1 U.S. Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.7.2.2 Key Country Dynamics
      • 7.7.2.3 Regulatory Framework
      • 7.7.2.4 Competitive Scenario
      • 7.7.2.5 Investments Scenario
    • 7.7.3 Canada
      • 7.7.3.1 Canada Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.7.3.2 Key Country Dynamics
      • 7.7.3.3 Regulatory Framework
      • 7.7.3.4 Competitive Scenario
      • 7.7.3.5 Investments Scenario
  • 7.8 Europe
    • 7.8.1 Europe Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.8.2 Uk
      • 7.8.2.1 Uk Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.2.2 Key Country Dynamics
      • 7.8.2.3 Regulatory Framework
      • 7.8.2.4 Competitive Scenario
      • 7.8.2.5 Investments Scenario
    • 7.8.3 Germany
      • 7.8.3.1 Germany Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.3.2 Key Country Dynamics
      • 7.8.3.3 Regulatory Framework
      • 7.8.3.4 Competitive Scenario
      • 7.8.3.5 Investments Scenario
    • 7.8.4 Spain
      • 7.8.4.1 Spain Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.4.2 Key Country Dynamics
      • 7.8.4.3 Regulatory Framework
      • 7.8.4.4 Competitive Scenario
      • 7.8.4.5 Investments Scenario
    • 7.8.5 France
      • 7.8.5.1 France Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.5.2 Key Country Dynamics
      • 7.8.5.3 Regulatory Framework
      • 7.8.5.4 Competitive Scenario
      • 7.8.5.5 Investments Scenario
    • 7.8.6 Italy
      • 7.8.6.1 Italy Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.6.2 Key Country Dynamics
      • 7.8.6.3 Regulatory Framework
      • 7.8.6.4 Competitive Scenario
      • 7.8.6.5 Investments Scenario
    • 7.8.7 Norway
      • 7.8.7.1 Norway Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.7.3 Regulatory Framework
      • 7.8.7.4 Competitive Scenario
      • 7.8.7.5 Investments Scenario
    • 7.8.8 Denmark
      • 7.8.8.1 Denmark Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.8.2 Key Country Dynamics
      • 7.8.8.3 Regulatory Framework
      • 7.8.8.4 Competitive Scenario
      • 7.8.8.5 Investments Scenario
    • 7.8.9 Sweden
      • 7.8.9.1 Sweden Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.8.9.2 Key Country Dynamics
      • 7.8.9.3 Regulatory Framework
      • 7.8.9.4 Competitive Scenario
      • 7.8.9.5 Investments Scenario
  • 7.9 Asia Pacific
    • 7.9.1 Asia-Pacific Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.9.2 Japan
      • 7.9.2.1 Japan Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.2.2 Key Country Dynamics
      • 7.9.2.3 Regulatory Framework
      • 7.9.2.4 Competitive Scenario
      • 7.9.2.5 Investments Scenario
    • 7.9.3 China
      • 7.9.3.1 China Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.3.2 Key Country Dynamics
      • 7.9.3.3 Regulatory Framework
      • 7.9.3.4 Competitive Scenario
      • 7.9.3.5 Investments Scenario
    • 7.9.4 India
      • 7.9.4.1 India Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.4.2 Key Country Dynamics
      • 7.9.4.3 Regulatory Framework
      • 7.9.4.4 Competitive Scenario
      • 7.9.4.5 Investments Scenario
    • 7.9.5 South Korea
      • 7.9.5.1 South Korea Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.5.2 Key Country Dynamics
      • 7.9.5.3 Regulatory Framework
      • 7.9.5.4 Competitive Scenario
      • 7.9.5.5 Investments Scenario
    • 7.9.6 Thailand
      • 7.9.6.1 Thailand Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.6.2 Key Country Dynamics
      • 7.9.6.3 Regulatory Framework
      • 7.9.6.4 Competitive Scenario
      • 7.9.6.5 Investments Scenario
    • 7.9.7 Australia
      • 7.9.7.1 Australia Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.9.7.2 Key Country Dynamics
      • 7.9.7.3 Regulatory Framework
      • 7.9.7.4 Competitive Scenario
      • 7.9.7.5 Investments Scenario
  • 7.10 Latin America
    • 7.10.1 Latin America Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.10.2 Brazil
      • 7.10.2.1 Brazil Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.10.2.2 Key Country Dynamics
      • 7.10.2.3 Regulatory Framework
      • 7.10.2.4 Competitive Scenario
      • 7.10.2.5 Investments Scenario
    • 7.10.3 Mexico
      • 7.10.3.1 Mexico Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.10.3.2 Key Country Dynamics
      • 7.10.3.3 Regulatory Framework
      • 7.10.3.4 Competitive Scenario
      • 7.10.3.5 Investments Scenario
    • 7.10.4 Argentina
      • 7.10.4.1 Argentina Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.10.4.2 Key Country Dynamics
      • 7.10.4.3 Regulatory Framework
      • 7.10.4.4 Competitive Scenario
      • 7.10.4.5 Investments Scenario
  • 7.11 MEA
    • 7.11.1 MEA Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
    • 7.11.2 South Africa
      • 7.11.2.1 South Africa Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.11.2.2 Key Country Dynamics
      • 7.11.2.3 Regulatory Framework
      • 7.11.2.4 Competitive Scenario
      • 7.11.2.5 Investments Scenario
    • 7.11.3 Saudi Arabia
      • 7.11.3.1 Saudi Arabia Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.11.3.2 Key Country Dynamics
      • 7.11.3.3 Regulatory Framework
      • 7.11.3.4 Competitive Scenario
      • 7.11.3.5 Investments Scenario
    • 7.11.4 UAE
      • 7.11.4.1 UAE Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.11.4.2 Key Country Dynamics
      • 7.11.4.3 Regulatory Framework
      • 7.11.4.4 Competitive Scenario
      • 7.11.4.5 Investments Scenario
    • 7.11.5 Kuwait
      • 7.11.5.1 Kuwait Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
      • 7.11.5.2 Key Country Dynamics
      • 7.11.5.3 Regulatory Framework
      • 7.11.5.4 Competitive Scenario
      • 7.11.5.5 Investments Scenario

Chapter 8 Retinal Disorder Treatment Market - Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 8.1.1 Ansoff Matrix
    • 8.1.2 Heat Map Analysis
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List Of Key Distributors And Channel Partners
    • 8.3.2 Key Customers
    • 8.3.3 Key Company Market Share Analysis, 2022
  • 8.4 Public Companies
    • 8.4.1 Company Market Position Analysis
    • 8.4.2 Company Market Share, By Region
    • 8.4.3 Competitive Dashboard Analysis
      • 8.4.3.1 Market Differentiators
  • 8.5 Private Companies
    • 8.5.1 List Of Key Emerging Companies
  • 8.6 Company Profiles
    • 8.6.1 Graybug Vision, Inc.
      • 8.6.1.1 Company Overview
      • 8.6.1.2 Product Benchmarking
      • 8.6.1.3 Strategic Initiatives
    • 8.6.2 Shire (Takeda Pharmaceutical Company Limited)
      • 8.6.2.1 Company Overview
      • 8.6.2.2 Financial Performance
      • 8.6.2.3 Product Benchmarking
    • 8.6.3 Regeneron Pharmaceuticals Inc.
      • 8.6.3.1 Company Overview
      • 8.6.3.2 Financial Performance
      • 8.6.3.3 Product Benchmarking
      • 8.6.3.4 Strategic Initiatives
    • 8.6.4 Acucela Inc.
      • 8.6.4.1 Company Overview
      • 8.6.4.2 Financial Performance
      • 8.6.4.3 Product Benchmarking
    • 8.6.5 Allergan Plc. (Abbvie Inc.)
      • 8.6.5.1 Company Overview
      • 8.6.5.2 Financial Performance
      • 8.6.5.3 Product Benchmarking
      • 8.6.5.4 Strategic Initiatives
    • 8.6.6 Pfizer, Inc.
      • 8.6.6.1 Company Overview
      • 8.6.6.2 Financial Performance
      • 8.6.6.3 Product Benchmarking
    • 8.6.7 Bayer Ag
      • 8.6.7.1 Company Overview
      • 8.6.7.2 Financial Performance
      • 8.6.7.3 Product Benchmarking
      • 8.6.7.4 Strategic Initiatives
    • 8.6.8 Santen Pharmaceuticals Co. Ltd.
      • 8.6.8.1 Company Overview
      • 8.6.8.2 Financial Performance
      • 8.6.8.3 Product Benchmarking
      • 8.6.8.4 Strategic Initiatives
    • 8.6.9 Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
      • 8.6.9.1 Company Overview
      • 8.6.9.2 Financial Performance
      • 8.6.9.3 Product Benchmarking
      • 8.6.9.4 Strategic Initiatives
    • 8.6.10 Kubota Pharmaceutical Holdings Co., Ltd.
      • 8.6.9.1 Company Overview
      • 8.6.9.2 Financial Performance
      • 8.6.9.3 Product Benchmarking
      • 8.6.9.4 Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Global Retinal Disorder Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 Global Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 4 Global Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 6 Global Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 9 North America Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 11 North America Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 12 U.S. Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 15 U.S. Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Canada Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 19 Canada Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Europe Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 24 Europe Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 U.K. Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 U.K. Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 U.K. Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 28 U.K. Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 Germany Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 30 Germany Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 32 Germany Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 France Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 34 France Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 France Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 36 France Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Italy Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 40 Italy Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Spain Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 44 Spain Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Denmark Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 46 Denmark Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 48 Denmark Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 49 Sweden Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 Sweden Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 52 Sweden Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 Norway Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Norway Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 56 Norway Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Japan Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Japan Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 65 Japan Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 China Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 67 China Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 China Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 69 China Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 India Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 71 India Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 India Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 73 India Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74 South Korea Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 75 South Korea Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 77 South Korea Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 Thailand Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Thailand Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 Thailand Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 81 Thailand Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Australia Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Australia Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Australia Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 85 Australia Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Latin America Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 87 Latin America Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 88 Latin America Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 90 Latin America Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 Mexico Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 Mexico Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 Mexico Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 94 Mexico Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 95 Brazil Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 96 Brazil Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 97 Brazil Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 98 Brazil Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 99 Argentina Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 100 Argentina Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 102 Argentina Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 103 MEA Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 104 MEA Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 105 MEA Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 MEA Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 107 MEA Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 108 South Africa Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 109 South Africa Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 111 South Africa Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 116 UAE Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 117 UAE Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Retinal Disorder Treatment Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping
  • Fig. 15 Retinal Disorder Treatment market: Type outlook and key takeaways
  • Fig. 16 Retinal Disorder Treatment market: Type movement analysis & market share 2022 & 2030
  • Fig. 17 Macular degeneration market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Diabetic retinopathy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Other types market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Retinal Disorder Treatment market: Dosage form outlook and key takeaways
  • Fig. 21 Retinal Disorder Treatment market: Dosage form movement analysis & market share 2022 & 2030
  • Fig. 22 Gels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Capsule and tablets market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Retinal Disorder Treatment market: Distribution channel outlook and key takeaways
  • Fig. 28 Retinal Disorder Treatment market: Distribution channel movement analysis & market share 2022 & 2030
  • Fig. 29 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Regional Marketplace: Key Takeaways
  • Fig. 33 Regional Outlook, 2022 & 2030
  • Fig. 34 Regional Market Dashboard
  • Fig. 35 Regional Market Place: Key Takeaways
  • Fig. 36 North America, SWOT Analysis
  • Fig. 37 Europe, SWOT Analysis
  • Fig. 38 Asia Pacific, SWOT Analysis
  • Fig. 39 Latin America, SWOT Analysis
  • Fig. 40 MEA, SWOT Analysis
  • Fig. 41 North America
  • Fig. 42 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.S.
  • Fig. 44 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Canada
  • Fig. 46 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Europe
  • Fig. 48 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 49 UK
  • Fig. 50 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Germany
  • Fig. 52 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 53 France
  • Fig. 54 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Italy
  • Fig. 56 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Spain
  • Fig. 58 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark
  • Fig. 60 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Sweden
  • Fig. 62 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Norway
  • Fig. 64 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific
  • Fig. 66 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Japan
  • Fig. 68 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 China
  • Fig. 70 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 India
  • Fig. 72 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Australia
  • Fig. 74 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand
  • Fig. 76 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea
  • Fig. 78 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America
  • Fig. 80 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil
  • Fig. 82 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Mexico
  • Fig. 84 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina
  • Fig. 86 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 MEA
  • Fig. 88 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 South Africa
  • Fig. 90 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Saudi Arabia
  • Fig. 92 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 93 UAE
  • Fig. 94 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait
  • Fig. 96 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Strategy Mapping